CHU de Rouen - Accueil
10
6
6
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection
Role: collaborator
NEUROIMAGING OF ADOLESCENT BORDERLINE PERSONALITY DISORDER WITH AND WITHOUT POST-TRAUMATIC STRESS DISORDER
Role: collaborator
Multimodal Prehabilitation in Patients with Lung Cancer Undergoing Neoadjuvant Therapy
Role: collaborator
Prospective Study to Assess Medical Performance of Optical Mapping and Long Read Sequencing in Detecting Numerical and Structural Chromosome Abnormalities
Role: collaborator
Place of Nasogastric Tube in Uncomplicated Adhesive Small Bowel Obstruction
Role: collaborator
French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV
Role: collaborator
Evaluation of the POSOS Device for Iatrogenesis Detection in Clinical History? A Vignettes Study
Role: collaborator
S-ICD French Cohort Study (HONEST)
Role: collaborator
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
Role: collaborator
Old Red Blood Cell In Renal Transplantation
Role: collaborator
All 10 trials loaded